No Detail Found!

Intrathecal anti-tetanus human immunoglobulin in the treatment of neonatal tetanus.

Author(s)
Ameer Ahmad Department of Paediatrics, Quaid-i-Azam Medical College/ Bahawal Victoria Hospital, Bahawalpur, Pakistan
Imran Qaisar Department of Paediatrics, Quaid-i-Azam Medical College/ Bahawal Victoria Hospital, Bahawalpur, Pakistan
Mohammad Naeem Department of Paediatrics, Quaid-i-Azam Medical College/ Bahawal Victoria Hospital, Bahawalpur, Pakistan
Attaullah Mazhar Department of Paediatrics, Quaid-i-Azam Medical College/ Bahawal Victoria Hospital, Bahawalpur, Pakistan
Mohammad Ashfaq Department of Paediatrics, National Institute of Child Health (NICH), Karachi, Pakistan
Abstract
Objective: To determine the outcome of tetanus in neonates treated with intrathecal tetanus immunoglobulin in terms of mortality and hospital stay. Study Design: Experimental study. Place and Duration of Study: Paediatric Unit I, Bahawal Victoria Hospital, Bahawalpur, from April 2004 to December 2007. Methodology: Seventy neonates with diagnosis of neonatal tetanus were included in the study. The neonates with fits due to causes other than tetanus were excluded. Thirty five patients received intrathecal immunoglobulin in addition to standard treatment (group A) while, the other 35 patients received only standard treatment (group B). The mortality and duration of hospital stay in 2 groups were recorded. Results: In group A, mean duration of hospital stay was 10 days while, in group B it was 13 days (p
Publication Details
Page(s) 539-541
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 21, Issue: 9, Year: 2011

Request the full text from PASTIC

0

Citations

0

Downloads

78

Views